| Ochsner Clinic Foundation | |
| 1516 Jefferson Hwy, New Orleans, Louisiana 70121 | |
| (504) 842-3000 | |
| Name | Ochsner Clinic Foundation |
|---|---|
| Type | Acute Care Hospital |
| Location | 1516 Jefferson Hwy, New Orleans, Louisiana |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 190036 |
| NPI Number | 1083062293 |
| Organization Name | OCHSNER CLINIC FOUNDATION |
| Address | 1514 Jefferson Hwy, New Orleans, LA 70121 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 504-842-3000 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1437416989 |
| Organization Name | OCHSNER CLINIC FOUNDATION |
| Address | 1514 Jefferson Hwy, Brent House Room 643, New Orleans, LA 70121 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 504-842-3000 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1659798536 |
| Organization Name | OCHSNER MEDICAL CENTER |
| Address | 1514 Jefferson Hwy, New Orleans, LA 70121 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 504-842-4796 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1689965410 |
| Organization Name | OCHSNER CLINIC FOUNDATION |
| Address | 1514 Jefferson Hwy, New Orleans, LA 70121 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 251-689-3093 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1710276407 |
| Organization Name | OCHSNER CLINIC FOUNDATION |
| Address | 101 W 29th St Apt 1r, Baltimore, MD 21218 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 251-689-3093 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1770021859 |
| Organization Name | OCHSNER HEALTH SYSTEM |
| Address | 1514 Jefferson Hwy, New Orleans, LA 70121 |
| Hospital Type | Special Hospital |
| Phone Number | 504-842-3000 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1811973100 |
| Organization Name | OCHSNER CLINIC FOUNDATION |
| Doing Business As | OCHSNER MEDICAL CENTER ACUTE |
| Address | 1516 Jefferson Hwy, New Orleans, LA 70121 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 504-842-3000 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| NPI Number | 1982947818 |
| Organization Name | OCHSNER CLINIC FOUNDATION |
| Address | 1514 Jefferson Hwy, New Orleans, LA 70121 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 504-842-3260 |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona. The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.
Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.
Drug Enforcement Administration (DEA) Administrator Karen P. Tandy has announced the results of Operation "Cyber Chase", a year-long Organized Crime Drug Enforcement Task Force (OCDETF) investigation that targeted international Internet pharmaceutical traffickers operating in the United States, India, Asia, Europe and the Caribbean. These e-traffickers distributed drugs world-wide using "rogue" Internet pharmacies.
Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.
› Verified 1 days ago
University Medical Center New Orleans Acute Care Hospital Location: 2000 Canal Street, New Orleans, Louisiana 70112 Phone: (504) 903-3000 | |
Ochsner Clinic Foundation Acute Care Hospital Location: 1516 Jefferson Hwy, New Orleans, Louisiana 70121 Phone: (504) 842-3000 | |
Touro Infirmary Acute Care Hospital Location: 1401 Foucher Street, New Orleans, Louisiana 70115 Phone: (504) 897-8247 | |
Tulane Medical Center Acute Care Hospital Location: 1415 Tulane Ave, New Orleans, Louisiana 70112 Phone: (504) 988-5263 | |
St Charles Surgical Hospital Llc Acute Care Hospital Location: 1717 St Charles Ave, New Orleans, Louisiana 70130 Phone: (504) 529-6600 | |
New Orleans East Hospital Acute Care Hospital Location: 5620 Read Blvd, New Orleans, Louisiana 70127 Phone: (504) 592-6600 |